Tamoxifen and the factor V Leiden mutation.
Cuzick
Jack
J
D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D020847:Estrogen Receptor Modulators / Q000008:administration & dosage / Q000009:adverse effects*; D005165:Factor V / Q000235:genetics*; D005260:Female; D006801:Humans; D009154:Mutation; D015995:Prevalence; D012307:Risk Factors; D013629:Tamoxifen / Q000008:administration & dosage / Q000009:adverse effects*; D013923:Thromboembolism / Q000139:chemically induced / Q000209:etiology* / Q000235:genetics
D018931:Antineoplastic Agents, Hormonal; D020847:Estrogen Receptor Modulators; C095381:factor V Leiden; D013629:Tamoxifen; D005165:Factor V